Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 1,501 shares at $20.00 ($30K) on 2024-02-12, disclosed to the SEC on 2024-02-14.
Scheduled sale ($30k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |